TV
Big Brother Caroline suffers depression
Published Thursday, Jan 4 2001, 11:45 GMT | By Neil Wilkes
Big Brother contestant Caroline O'Shea is suffering from depression after a failed career in television and music.
According to the Daily Star, Caroline's album has been rejected by all record companies, and she is in dispute with Channel 4 producers over money.
"People think I'm a millionairess because I've been on TV and to a few showbiz parties. But that couldn't be further from the truth. I'm even arguing with Channel 4 over money they owe me," she said.
"After Big Brother, I was on a high - then a few weeks later I got very depressed. I now read about Craig and Nick and can believe they will each make a million. But I have made nothing like that. I don't think people realise this. I was at a clothes sale recently when a shop assistant recognised me and seemed surprised I was bargain-hunting."
According to the Daily Star, Caroline's album has been rejected by all record companies, and she is in dispute with Channel 4 producers over money.
"People think I'm a millionairess because I've been on TV and to a few showbiz parties. But that couldn't be further from the truth. I'm even arguing with Channel 4 over money they owe me," she said.
"After Big Brother, I was on a high - then a few weeks later I got very depressed. I now read about Craig and Nick and can believe they will each make a million. But I have made nothing like that. I don't think people realise this. I was at a clothes sale recently when a shop assistant recognised me and seemed surprised I was bargain-hunting."
Tube Talk
'Skins': The most violent episode ever?Tube Talk previews this week's violent episode of the E4 drama Skins.
TV Interviews
'Celebrity Apprentice' Debbie Gibson Q&ADebbie Gibson opens up about her Celebrity Apprentice experience.
Reality Bites
Does Simon Cowell have new SuBo?: VideoWatch a clip of Jonathan Antoine, who is tipped for success on BGT.
TV Ratings
'Take Me Out' climbs to 5.1mThe ITV1 dating show fails to register a significant boost despite last week's controversy.













